Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
10.11
+0.69 (7.32%)
At close: May 20, 2026, 4:00 PM EDT
9.93
-0.18 (-1.78%)
After-hours: May 20, 2026, 7:23 PM EDT
Beta Bionics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Beta Bionics stock has a consensus rating of "Buy" and an average price target of $19.18. The average 1-year stock price forecast is 89.71% higher than the current stock price, while the lowest is $11 (+8.80%) and the highest is $32 (+216.52%).
Price Target: $19.18 (+89.71%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Beta Bionics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 5 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 12 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $23 → $11 | Hold | Maintains | $23 → $11 | +8.80% | May 18, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $25 → $24 | Buy | Maintains | $25 → $24 | +137.39% | Apr 22, 2026 |
| Stifel | Stifel | Strong Buy Maintains $22 → $20 | Strong Buy | Maintains | $22 → $20 | +97.82% | Apr 22, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $18 | Strong Buy | Maintains | $25 → $18 | +78.04% | Apr 15, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +97.82% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
136.29M
from 100.25M
Increased by 35.95%
Revenue Next Year
183.99M
from 136.29M
Increased by 35.00%
EPS This Year
-2.25
from -1.81
EPS Next Year
-2.20
from -2.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 144.2M | 203.7M | |||||
| Avg | 136.3M | 184.0M | |||||
| Low | 128.4M | 159.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 43.8% | 49.5% | |||||
| Avg | 35.9% | 35.0% | |||||
| Low | 28.1% | 16.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.91 | -1.72 | |||
| Avg | -2.25 | -2.20 | |||
| Low | -2.33 | -2.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.